- Lobbying
- orchard AND therapeutics AND north AND america
Lobbying Arrangements Results for 'Orchard Therapeutics North America'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Access for inpatient gene therapies. Monitor newborn screening issues. H.R.2666 - MVP Act. |
Orchard Therapeutics North America
|
LMH STRATEGIC SOLUTIONS | |||
Details Newborn screening; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062). |
Orchard Therapeutics North America
|
Crossroads Strategies, LLC | |||
Details Issues related to gene therapies for rare diseases. |
Orchard Therapeutics North America
|
Sims Strategies, LLC | |||
Details Increased funding for the Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention in the FY 2022 Labor-HHS Appropriations Bill Issues related to funding for th... |
Cornerstone Government Affairs (on behalf of RUSP Coalition)
|
Avenue Solutions | |||
Details FY 2023 Labor HHS appropriations bill: Funding for the CDC Newborn Screening program |
Orchard Therapeutics North America
|
Cornerstone Government Affairs, Inc. | |||
Details Access and coverage of inpatient drugs in H.R. 2666 - Medicaid VBPs for Patients (MVP) Act. Education and awareness of rare and ultra rare diseases and patient access to orphan drugs. Education an... |
Orchard Therapeutics North America
|
THE MCMANUS GROUP |